Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
12.29
-1.31 (-9.60%)
At close: Apr 1, 2025, 4:00 PM
12.21
-0.08 (-0.65%)
After-hours: Apr 1, 2025, 7:23 PM EDT

Denali Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-422.77-145.22-325.99-290.5871.14
Upgrade
Depreciation & Amortization
1.0916.7310.388.598.53
Upgrade
Loss (Gain) From Sale of Assets
-14.54----
Upgrade
Asset Writedown & Restructuring Costs
7.9----
Upgrade
Loss (Gain) From Sale of Investments
-35.12-43.95-1.648.750.06
Upgrade
Stock-Based Compensation
102.88108.199.8585.2550.35
Upgrade
Other Operating Activities
-4.07-3.72-3.29-2.98-2.32
Upgrade
Change in Accounts Payable
1.442.432.273.71-1.62
Upgrade
Change in Unearned Revenue
--290.53-34.46-15.66278.17
Upgrade
Change in Other Net Operating Assets
15.5-1.838.16-8.4611.86
Upgrade
Operating Cash Flow
-347.69-357.99-244.72-211.39416.15
Upgrade
Capital Expenditures
-15.91-12.94-17.83-8.5-3.1
Upgrade
Investment in Securities
-72.84262.25-123.55-13.13-620.11
Upgrade
Investing Cash Flow
-88.76249.31-141.39-21.63-623.21
Upgrade
Long-Term Debt Repaid
-32.34----
Upgrade
Net Debt Issued (Repaid)
-32.34----
Upgrade
Issuance of Common Stock
517.1217.82311.7319.35634.75
Upgrade
Other Financing Activities
-0.48--1.06--
Upgrade
Financing Cash Flow
484.317.82310.6719.35634.75
Upgrade
Net Cash Flow
47.85-90.86-75.43-213.67427.7
Upgrade
Free Cash Flow
-363.61-370.93-262.55-219.89413.06
Upgrade
Free Cash Flow Margin
--112.22%-242.06%-451.88%123.06%
Upgrade
Free Cash Flow Per Share
-2.21-2.70-2.09-1.813.67
Upgrade
Cash Interest Paid
0.3----
Upgrade
Cash Income Tax Paid
-00.050.21-
Upgrade
Levered Free Cash Flow
-208.83-290.45-141.03200.41109.03
Upgrade
Unlevered Free Cash Flow
-208.64-290.45-141.03200.41109.03
Upgrade
Change in Net Working Capital
-16.97279.420.47-299.91-14.05
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q